Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. | Cerebrovascular Disease | JAMA Neurology | JAMA Network

Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. | Cerebrovascular Disease | JAMA Neurology | JAMA Network

Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic AttackSecondary Analysis of a Randomized Clinical Trial

Yuesong Pan, PhD^1,2,3,4; Weiqi Chen, MD, PhD^1,2,3,4; Yilong Wang, MD, PhD^1,2,3,4; et alHao Li, PhD^1,2,3,4; S. Claiborne Johnston, MD, PhD⁵; Tabassome Simon, MD, PhD^6,7,8; Xingquan Zhao, MD, PhD^1,2,3,4; Liping Liu, MD, PhD^1,2,3,4; David Wang, DO^9,10; Xia Meng, MD, PhD^1,2,3,4; Yongjun Wang, MD^1,2,3,4; for the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) Investigators

Author Affiliations

JAMA Neurol. Published online February 11, 2019. doi:10.1001/jamaneurol.2018.4775